0
Title
User
LIVE NOW
LIVE NOW
Title
User
Sign In
Home
Trending
Sign In
Audios and Videos
Videos
Audios
Channels
Browse Channels
Categories
Acute Lymphoblastic Leukemia
5634
Acute Myelogenous Leukemia
176
Bladder Cancer
56
Bone Metastases
1
Brain Cancer
28
Breast Cancer
143
Business Management
2
Cervical Cancer
3
Chronic Lymphocytic Leukemia
175
Chronic Myelogenous Leukemia
26
Colorectal Cancer
76
Gastrointestinal Cancer
73
General
254
Head and Neck Cancers
39
Hematologic Malignancies
165
Hodgkin Lymphoma
19
Immunotherapy
105
Kidney Cancer
366
Liver Cancer
11
Lymphoma
145
Melanoma and Skin Cancer
52
Multiple Myeloma
391
Myeloproliferative Disease
17
News
143
Non-Hodgkin Lymphoma
63
Non-Small Cell Lung Cancer
276
Other
116
Ovarian Cancer
10
Pancreatic Cancer
57
Patient Resources
28
Pediatric Cancer
1
Prostate Cancer
171
Sickle Cell
17
Small Cell Lung Cancer
60
Soft Tissue Sarcoma
9
Supportive Care
42
Testicular Cancer
2
Urology
9
Uterine Cancer
2
About
Contact
PharmaMar
Subscribe
0
My videos
0:04:01
Pascal Besman, COO Pharmamar - PharmaMar to submit New Drug Application (NDA) for lurbinectedin
Pascal Besman, COO Pharmamar - PharmaMar to submit New Drug Application (NDA) for lurbinectedin under accelerated approval in SCLC in the USA. Pascal Besman, Pharmamar COO discusses advantages and potential limitations of the new drug.
Small Cell Lung Cancer
74 Views
7 months ago
PharmaMar
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
0:02:13
Taofeek Owonikoko MD, PhD, MSCR - Lurbinectedin, a potential practice changing drug if approved
Small Cell Lung Cancer
Free
48 Views
7 months ago
PharmaMar
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
0:07:54
Hossein Borghaei, DO, MS - New Drug Application (NDA) for lurbinectedin
Small Cell Lung Cancer
Free
58 Views
7 months ago
PharmaMar
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
00:29:12
Spanish Version - Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent trial
Small Cell Lung Cancer
Free
449 Views
10 months ago
PharmaMar
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
00:28:53
Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent trial
Small Cell Lung Cancer
Free
874 Views
10 months ago
PharmaMar
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
00:00:28
Luis G. Paz-Ares, MD, PHD Special Presentation June 1st, 2019 McCormick Place Hall D2, 3pm
Small Cell Lung Cancer
Free
579 Views
10 months ago
PharmaMar
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
